Send to

Choose Destination
J Thorac Dis. 2018 Nov;10(Suppl 33):S4061-S4064. doi: 10.21037/jtd.2018.09.106.

Circulating tumor DNA analysis in patients with EGFR mutant lung cancer.

Author information

Department of Medicine, University of California, San Francisco, CA, USA.
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.

Conflict of interest statement

Conflicts of Interest: TG Bivona is a consultant or advisory board member to Revolution Medicines, Array Biopharma, Novartis, AstraZeneca and receives research support from Revolution Medicines and Novartis. S Nanjo receives research support from AstraZeneca.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center